{"url_path":"/sec/ach/8-k/2026-06-15/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-15","source_url":"https://www.sec.gov/Archives/edgar/data/75252/0001193125-26-271115-index.html","accession_number":"0001193125-26-271115","cik":"0000075252","ticker":"ACH","issuer_name":"ACCENDRA HEALTH INC/VA/","edgar_url":"https://www.sec.gov/Archives/edgar/data/75252/0001193125-26-271115-index.html","primary_entity_key":"0000075252","primary_entity_name":"ACCENDRA HEALTH INC/VA/"},"word_count":393,"has_tables":true,"body_markdown":"Item 9.01.\n\nFinancial Statements and Exhibits.\n\n(d) Exhibits.\n\n \n\nExhibit\n\nNumber\n\n \nDescription\n\n 4.1\n \n[First Lien Indenture, dated as of June 15, 2026, by and among the Company, the guarantors named therein and Regions Bank, as trustee and as collateral agent.](d100115dex41.htm)\n\n 4.2\n \n[Form of Global Note for the 9.000% Senior Secured Notes due 2032 (included as Exhibit A to Exhibit 4.1 hereto).](d100115dex41.htm)\n\n 4.3\n \n[Second Lien Indenture, dated as of June 15, 2026, by and among the Company, the guarantors named therein and Regions Bank, as trustee and as collateral agent.](d100115dex43.htm)\n\n 4.4\n \n[Form of Global Note for the 9.750% Senior Secured Notes due 2033 (included as Exhibit A to Exhibit 4.3 hereto).](d100115dex43.htm)\n\n 4.5\n \n[Second Supplemental Indenture, dated as of June 9, 2026, by and among the Company, the guarantors party thereto and Regions Bank, as trustee, to the Indenture dated as of March 10, 2021.](d100115dex45.htm)\n\n 4.6\n \n[Second Supplemental Indenture, dated as of June 9, 2026, by and among the Company, the guarantors party thereto and Regions Bank, as trustee, to the Indenture dated as of March 29, 2022.](d100115dex46.htm)\n\n10.1\n \n[Amendment No. 4 to Credit Agreement and Consent, dated June 15, 2026, by and among the Company, as Parent Borrower, the other borrowers party thereto, the guarantors party thereto, each consenting lender party thereto and Bank of America, N.A., as administrative agent, collateral agent, letter of credit issuer and swingline lender.*](d100115dex101.htm)\n\n10.2\n \n[Amendment No. 2 to Term Loan Credit Agreement and Consent, dated June 15, 2026, by and among the Company, as Parent Borrower, the other borrowers party thereto, the guarantors party thereto, each consenting Term A-1 Term Lender party thereto, each consenting Term B-1 Term Lender party thereto and JPMorgan Chase Bank, N.A. as administrative agent and collateral agent.*](d100115dex102.htm)\n\n99.1\n \n[Press Release dated June 10, 2026.](d100115dex991.htm)\n\n104\n \nCover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document).\n\n \n\n*\n\nSchedules and Exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The registrant hereby agrees to supplementally furnish to the SEC upon request any omitted schedule or exhibit.\n\n \n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\n \nACCENDRA HEALTH, INC.\n\n \n\n \n\n \n\n/s/ Heath H. Galloway\n\nJune 15, 2026\n \n\n \n\n \nHeath H. Galloway\n\n \n\n \n\n \nExecutive Vice President, General Counsel and Corporate Secretary"}